Report cover image

Bone Growth Products Market - Global Outlook & Forecast 2022-2027

Publisher Arizton Advisory and Intelligence
Published Mar 24, 2022
Length 317 Pages
SKU # ARZ17043159

Description

Bone Growth Products Market - Global Outlook & Forecast 2022-2027

In-depth Analysis on Market Size, Share, & Trends Analysis Report by Product Type, Application, End-user and Geography are included in this Global Bone Growth Products Market Report

The global bone growth products market is majorly driven by the rising incidence of bone and joint disorders, growing demand for minimally invasive and non-invasive treatment options for people suffering from various orthopedic disorders, and the growing elderly population.

The bone growth products market by revenue is expected to grow at a CAGR of over 3.60% during the period 2022–2027.

GLOBAL BONE GROWTH PRODUCTS MARKET SEGMENTATION

The bone growth stimulator devices segment dominates the global bone growth products market, accounting for a share of 51.12%, followed by bone morphogenetic protein with 39.15% in 2021.

Based on end-users, the market is segmented into hospitals & clinics, specialty orthopedic and spine centers, and ASCs. Hospitals & clinics segment is dominating in the market whereas, specialty orthopedic & spine centers is growing at 4.47% CAGR as patients increasingly prefer specialty spine care centers over multi-specialty hospitals.

Market Segmentation by Product Type
  • Bone Growth Stimulator Device
  • Bone Morphogenic Protein
  • Platelet Rich Plasma
Market Segmentation by Application
  • Spinal Fusion Surgeries
  • Oral and Maxillofacial Surgeries
  • Delayed Union and Non-Union Bone Fracture
  • Others
Market Segmentation by Application
  • Hospitals and Clinic
  • Specialty Orthopaedic and Spine Center
  • Ambulatory Surgery Centers
VENDOR ANALYSIS

Global players in the market are adopting acquisition strategies to remain competitive and extend their presence across geographies for higher market share. In addition, the competition among tier II and III players is high, with many regional and local players offering a diverse range of bone growth products.

PROMINENT VENDORS
  • Bioventus
  • DJO
  • Johnson & Johnson
  • Medtronic
  • Orthofix Medical
  • Stryker
  • Zimmer Biomet
OTHER PROMINENT VENDORS
  • BTT Health
  • Elizur
  • Fintek Bio-Electric
  • Isto Biologics
  • ITO
  • Kinex Medical Company
  • Ossatec Benelux
  • Osteotec
  • Paragon 28
  • Royal Biologics
  • Stimulate Health
  • Smith+Nephew
  • SpineVision
  • VQ OrthoCare
GEOGRAPHICAL ANALYSIS

In 2021, North America accounted for a revenue share of 41.45% in the global bone growth products market. The regional market is expected to retain its dominance during the forecast period and is likely to grow at a lesser CAGR than APAC as it has reached maturity.

Market Segmentation by Geography
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • APAC
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • Turkey
THE REPORT INCLUDES:

1. The analysis of the global Bone Growth Products market provides market size and growth rate for the forecast period 2022-2027.

2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Bone Growth Products market.

3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.

4. It offers a complete overview of market segments and the regional outlook of the global Bone Growth Products market.

5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.

Table of Contents

317 Pages
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY END-USERS
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 MARKET OPPORTUNITIES & TRENDS
8.1 SELF-POWERED IMPLANTABLE BONE GROWTH DEVICES STIMULATE FAST BONE HEALING
8.2 USE OF BONE MORPHOGENIC PROTEINS AS ALTERNATIVE TO AUTOGRAFTS
8.3 NEXT GENERATION MOBILE BONE GROWTH STIMULATION DEVICES
9 MARKET GROWTH ENABLERS
9.1 GROWTH IN TARGET POPULATION
9.2 INCREASE IN DEMAND FOR NON-INVASIVE & SAFER SURGICAL TREATMENTS
9.3 RISE IN STRATEGIC ACQUISITIONS & NEW BONE GROWTH PRODUCT LAUNCHES
10 MARKET GROWTH RESTRAINTS
10.1 STRINGENT REGULATORY APPROVAL PROCESS FOR BONE GROWTH PRODUCTS
10.2 SIDE-EFFECTS ASSOCIATED WITH BMP-BASED ORTHOPEDIC TREATMENT
10.3 AVAILABILITY OF MULTIPLE ALTERNATIVES
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
    11.2.1 GEOGRAPHY INSIGHTS
    11.2.2 PRODUCT INSIGHTS
    11.2.3 APPLICATION INSIGHTS
    11.2.4 END-USER INSIGHTS
11.3 FIVE FORCES ANALYSIS
    11.3.1 THREAT OF NEW ENTRANTS
    11.3.2 BARGAINING POWER OF SUPPLIERS
    11.3.3 BARGAINING POWER OF BUYERS
    11.3.4 THREAT OF SUBSTITUTES
    11.3.5 COMPETITIVE RIVALRY
12 PRODUCT ANALYSIS
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 BONE GROWTH STIMULATOR DEVICES
    12.3.1 MARKET OVERVIEW
    12.3.2 MARKET SIZE & FORECAST
    12.3.3 BONE GROWTH STIMULATION DEVICES SEGMENTATION: BY GEOGRAPHY
12.4 BONE MORPHOGENETIC PROTEIN (BMP)
    12.4.1 MARKET OVERVIEW
    12.4.2 MARKET SIZE & FORECAST
    12.4.3 BONE MORPHOGENETIC PROTEINS SEGMENTATION: BY GEOGRAPHY
12.5 PLATELET RICH PLASMA
    12.5.1 MARKET OVERVIEW
    12.5.2 MARKET SIZE & FORECAST
    12.5.3 PLATELET RICH PLASMA: BY GEOGRAPHY
13 APPLICATION SEGMENTATION
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 SPINAL FUSION SURGERIES
    13.3.1 MARKET OVERVIEW
    13.3.2 MARKET SIZE & FORECAST
    13.3.3 SPINAL FUSION SURGERIES: BY GEOGRAPHY
13.4 ORAL & MAXILLOFACIAL SURGERIES
    13.4.1 MARKET OVERVIEW
    13.4.2 MARKET SIZE & FORECAST
    13.4.3 ORAL & MAXILLOFACIAL SURGERIES SEGMENTATION: BY GEOGRAPHY
13.5 DELAYED UNION & NON-UNION BONE FRACTURES
    13.5.1 MARKET OVERVIEW
    13.5.2 MARKET SIZE & FORECAST
    13.5.3 DELAYED UNION & NON-UNION BONE FRACTURES SEGMENTATION: BY GEOGRAPHY
13.6 OTHERS
    13.6.1 MARKET OVERVIEW
    13.6.2 MARKET SIZE & FORECAST
    13.6.3 OTHERS SEGMENTATION: BY GEOGRAPHY
14 END-USER ANALYSIS
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 HOSPITALS & CLINICS
    14.3.1 MARKET OVERVIEW
    14.3.2 MARKET SIZE & FORECAST
    14.3.3 HOSPITALS & CLINICS SEGMENTATION: BY GEOGRAPHY
14.4 SPECIALTY ORTHOPEDIC & SPINE CENTERS
    14.4.1 MARKET OVERVIEW
    14.4.2 MARKET SIZE & FORECAST
    14.4.3 SPECIALTY ORTHOPEDIC & SPINE CENTERS SEGMENTATION: BY GEOGRAPHY
14.5 AMBULATORY SURGICAL CENTERS (ASC)
    14.5.1 MARKET OVERVIEW
    14.5.2 MARKET SIZE & FORECAST
    14.5.3 ASCS SEGMENTATION: BY GEOGRAPHY
15 GEOGRAPHIC INSIGHTS
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 GEOGRAPHIC OVERVIEW
16 NORTH AMERICA
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
    16.2.1 NORTH AMERICA PRODUCT TYPE SEGMENTATION
    16.2.2 NORTH AMERICA APPLICATION SEGMENTATION
    16.2.3 NORTH AMERICA END-USER SEGMENTATION
16.3 KEY COUNTRIES
    16.3.1 US: MARKET SIZE & FORECAST
    16.3.2 CANADA: MARKET SIZE & FORECAST
17 EUROPE
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
    17.2.1 EUROPE PRODUCT TYPE SEGMENTATION
    17.2.2 EUROPE APPLICATION SEGMENTATION
    17.2.3 EUROPE END-USER SEGMENTATION
17.3 KEY COUNTRIES
    17.3.1 GERMANY: MARKET SIZE & FORECAST
    17.3.2 FRANCE: MARKET SIZE & FORECAST
    17.3.3 UK: MARKET SIZE & FORECAST
    17.3.4 ITALY: MARKET SIZE & FORECAST
    17.3.5 SPAIN: MARKET SIZE & FORECAST
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
    18.2.1 APAC PRODUCT TYPE SEGMENTATION
    18.2.2 APAC APPLICATION SEGMENTATION
    18.2.3 APAC END-USER SEGMENTATION
18.3 KEY COUNTRIES
    18.3.1 CHINA: MARKET SIZE & FORECAST
    18.3.2 JAPAN: MARKET SIZE & FORECAST
    18.3.3 INDIA: MARKET SIZE & FORECAST
    18.3.4 AUSTRALIA: MARKET SIZE & FORECAST
    18.3.5 SOUTH KOREA: MARKET SIZE & FORECAST
19 LATIN AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
    19.2.1 LATIN AMERICA PRODUCT SEGMENTATION
    19.2.2 LATIN AMERICA APPLICATION SEGMENTATION
    19.2.3 LATIN AMERICA END-USER SEGMENTATION
19.3 KEY COUNTRIES
    19.3.1 BRAZIL: MARKET SIZE & FORECAST
    19.3.2 MEXICO: MARKET SIZE & FORECAST
    19.3.3 ARGENTINA: MARKET SIZE & FORECAST
20 MIDDLE EAST & AFRICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
    20.2.1 MIDDLE EAST & AFRICA PRODUCT TYPE SEGMENTATION
    20.2.2 MIDDLE EAST & AFRICA APPLICATION SEGMENTATION
    20.2.3 MIDDLE EAST & AFRICA END-USER SEGMENTATION
20.3 KEY COUNTRIES
    20.3.1 TURKEY: MARKET SIZE & FORECAST
    20.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    20.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
21.1 COMPETITION OVERVIEW
21.2 MARKET SHARE ANALYSIS
    21.2.1 BIOVENTUS
    21.2.2 DJO
    21.2.3 JOHNSON & JOHNSON
    21.2.4 MEDTRONIC
    21.2.5 ORTHOFIX
    21.2.6 STRYKER
    21.2.7 ZIMMER BIOMET
22 KEY COMPANY PROFILES
22.1 BIOVENTUS
    22.1.1 BUSINESS OVERVIEW
    22.1.2 PRODUCT OFFERINGS
    22.1.3 KEY STRATEGIES
    22.1.4 KEY STRENGTHS
    22.1.5 KEY OPPORTUNITIES
22.2 DJO
    22.2.1 BUSINESS OVERVIEW
    22.2.2 PRODUCT OFFERINGS
    22.2.3 KEY STRATEGIES
    22.2.4 KEY STRENGTHS
    22.2.5 KEY OPPORTUNITIES
22.3 JOHNSON & JOHNSON
    22.3.1 BUSINESS OVERVIEW
    22.3.2 PRODUCT OFFERINGS
    22.3.3 KEY STRATEGIES
    22.3.4 KEY STRENGTHS
    22.3.5 KEY OPPORTUNITIES
22.4 MEDTRONIC
    22.4.1 BUSINESS OVERVIEW
    22.4.2 PRODUCT OFFERINGS
    22.4.3 KEY STRATEGIES
    22.4.4 KEY STRENGTHS
    22.4.5 KEY OPPORTUNITIES
22.5 ORTHOFIX
    22.5.1 BUSINESS OVERVIEW
    22.5.2 PRODUCT OFFERINGS
    22.5.3 KEY STRATEGIES
    22.5.4 KEY STRENGTHS
    22.5.5 KEY OPPORTUNITIES
22.6 STRYKER
    22.6.1 BUSINESS OVERVIEW
    22.6.2 PRODUCT OFFERINGS
    22.6.3 KEY STRATEGIES
    22.6.4 KEY STRENGTHS
    22.6.5 KEY OPPORTUNITIES
22.7 ZIMMER BIOMET
    22.7.1 BUSINESS OVERVIEW
    22.7.2 PRODUCT OFFERINGS
    22.7.3 KEY STRATEGIES
    22.7.4 KEY STRENGTHS
    22.7.5 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS
23.1 ALTIS BIOLOGICS
    23.1.1 BUSINESS OVERVIEW
    23.1.2 PRODUCT OFFERINGS
23.2 BIO DYNAMIC TECHNOLOGIES
    23.2.1 BUSINESS OVERVIEW
    23.2.2 PRODUCT OFFERINGS
23.3 BTT HEALTH
    23.3.1 BUSINESS OVERVIEW
    23.3.2 PRODUCT OFFERINGS
23.4 CELLUMED
    23.4.1 BUSINESS OVERVIEW
    23.4.2 PRODUCT OFFERINGS
23.5 EASTERN DME
    23.5.1 BUSINESS OVERVIEW
    23.5.2 PRODUCT OFFERINGS
23.6 ELIZUR
    23.6.1 BUSINESS OVERVIEW
    23.6.2 PRODUCT OFFERINGS
23.7 EMCYTE
    23.7.1 BUSINESS OVERVIEW
    23.7.2 PRODUCT OFFERINGS
23.8 FINTEK BIO-ELECTRIC
    23.8.1 BUSINESS OVERVIEW
    23.8.2 PRODUCT OFFERINGS
23.9 IGEA
    23.9.1 BUSINESS OVERVIEW
    23.9.2 PRODUCT OFFERINGS
23.10 ITO
    23.10.1 BUSINESS OVERVIEW
    23.10.2 PRODUCT OFFERINGS
23.11 KINEX MEDICAL
    23.11.1 BUSINESS OVERVIEW
    23.11.2 PRODUCT OFFERINGS
23.12 OSSATEC BENELUX
    23.12.1 BUSINESS OVERVIEW
    23.12.2 PRODUCT OFFERINGS
23.13 PAIN REHAB PRODUCTS
    23.13.1 BUSINESS OVERVIEW
    23.13.2 PRODUCT OFFERINGS
23.14 ROYAL BIOLOGICS
    23.14.1 BUSINESS OVERVIEW
    23.14.2 PRODUCT OFFERINGS
23.15 SHENANDOAH BIOTECHNOLOGY
    23.15.1 BUSINESS OVERVIEW
    23.15.2 PRODUCT OFFERINGS
23.16 SMITH+NEPHEW
    23.16.1 BUSINESS OVERVIEW
    23.16.2 PRODUCT OFFERINGS
23.17 SPECIALIZED ORTHOPEDIC SOLUTIONS
<
    DD>23.17.1 BUSINESS OVERVIEW
    23.17.2 PRODUCT OFFERINGS
23.18 STIMULATE HEALTH
    23.18.1 BUSINESS OVERVIEW
    23.18.2 PRODUCT OFFERINGS
23.19 TERUMO
    23.19.1 BUSINESS OVERVIEW
    23.19.2 PRODUCT OFFERINGS
24 REPORT SUMMARY
24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
25.1 MARKET BY PRODUCT TYPE
    25.1.1 NORTH AMERICA: PRODUCT TYPE SEGMENTATION
    25.1.2 EUROPE: PRODUCT TYPE SEGMENTATION
    25.1.3 APAC: PRODUCT TYPE SEGMENTATION
    25.1.4 LATIN AMERICA: PRODUCT TYPE SEGMENTATION
    25.1.5 MIDDLE EAST & AFRICA: PRODUCT TYPE SEGMENTATION
25.2 MARKET BY APPLICATION
    25.2.1 NORTH AMERICA: APPLICATION SEGMENTATION
    25.2.2 EUROPE: APPLICATION SEGMENTATION
    25.2.3 APAC: APPLICATION SEGMENTATION
    25.2.4 LATIN AMERICA: APPLICATION SEGMENTATION
    25.2.5 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
25.3 MARKET BY END-USER
    25.3.1 NORTH AMERICA: END-USER SEGMENTATION
    25.3.2 EUROPE: END-USER SEGMENTATION
    25.3.3 APAC: END-USER SEGMENTATION
    25.3.4 LATIN AMERICA: END-USER SEGMENTATION
    25.3.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
25.4 MARKET BY GEOGRAPHY
    25.4.1 BONE GROWTH STIMULATOR DEVICES SEGMENTATION: BY GEOGRAPHY
    25.4.2 BONE MORPHOGENETIC PROTEIN SEGMENTATION: BY GEOGRAPHY
    25.4.3 PLATELET RICH PLASMA SEGMENTATION: BY GEOGRAPHY
    25.4.4 SPINAL FUSION SURGERIES SEGMENTATION: BY GEOGRAPHY
    25.4.5 ORAL & MAXILLOFACIAL SURGERIES SEGMENTATION: BY GEOGRAPHY
    25.4.6 DELAYED UNION & NON-UNION BONE FRACTURES: BY GEOGRAPHY
    25.4.7 OTHERS SEGMENTATION: BY GEOGRAPHY
    25.4.8 HOSPITALS & CLINICS SEGMENTATION: BY GEOGRAPHY
    25.4.9 SPECIALTY ORTHOPEDIC & SPINE CENTER SEGMENTATION: BY GEOGRAPHY
    25.4.10 ASCS SEGMENTATION: BY GEOGRAPHY
26 APPENDIX
26.1 ABBREVIATIONS

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us